Iowa HF658 caps cost-sharing for prescription insulin drugs at $25 per 31-day supply.
Iowa HF658 mandates that policies, contracts, or plans providing coverage for prescription drugs limit the cost-sharing for prescription insulin drugs to no more than $25 for a 31-day supply. This applies to rapid-acting, short-acting, intermediate-acting, and long-acting insulin drugs. The bill defines "cost-sharing" as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.